These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6755087)

  • 21. [Results of active preventive vaccination against hepatitis B with a German vaccine].
    Henning H; Laufs R; Kätzner K; Bredehorst R
    Z Gastroenterol; 1983 Mar; 21(3):111-4. PubMed ID: 6868717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost without benefit? The introduction of hepatitis B vaccine in Canada.
    Coates RA; Rankin JG
    Can Med Assoc J; 1983 May; 128(10):1158-60. PubMed ID: 6404544
    [No Abstract]   [Full Text] [Related]  

  • 23. [Efficacy of a French hepatitis B vaccine. Results of a multicenter clinical trial, using a placebo, with double-blind randomized administration].
    Crosnier J; Jungers P; Courouce AM; Laplanche A; Benhamou E; Degos F; Lacour B; Guesry P
    Bull Acad Natl Med; 1980 Nov; 164(8):764-76. PubMed ID: 7011486
    [No Abstract]   [Full Text] [Related]  

  • 24. Vaccination of children with malignant diseases with alum-absorbed hepatitis B vaccine--Immunogenicity studies.
    Arnold W; Baumann W
    Scand J Infect Dis Suppl; 1983; 38():33-6. PubMed ID: 6580724
    [No Abstract]   [Full Text] [Related]  

  • 25. What prophylactic measures are recommended for persons exposed to hepatitis?
    Harris JT; Fischer RG; Parks BR
    Pediatr Nurs; 1984; 10(3):228. PubMed ID: 6563515
    [No Abstract]   [Full Text] [Related]  

  • 26. The dose of hepatitis B vaccine.
    Seville P
    N Z Med J; 1988 Nov; 101(857):774. PubMed ID: 2972946
    [No Abstract]   [Full Text] [Related]  

  • 27. The new hepatitis vaccine.
    Carlisle WR
    J Med Assoc State Ala; 1982 Oct; 52(4):55-6. PubMed ID: 7142853
    [No Abstract]   [Full Text] [Related]  

  • 28. Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization.
    Hsu HM; Lu CF; Lee SC; Lin SR; Chen DS
    J Infect Dis; 1999 Feb; 179(2):367-70. PubMed ID: 9878020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preventive vaccination against hepatitis B].
    Polz MA
    Pol Tyg Lek; 1984 Aug; 39(33):1111-2. PubMed ID: 6390377
    [No Abstract]   [Full Text] [Related]  

  • 30. Age at presentation for infant immunization in Nigeria: implications for hepatitis B immunization.
    Sadoh AE; Eregie CO
    Public Health; 2008 Dec; 122(12):1318-20. PubMed ID: 18706664
    [No Abstract]   [Full Text] [Related]  

  • 31. Active immunization against hepatitis B in an area of high endemicity. Part II: Prevention of early infection of the child.
    Maupas P; Chiron JP; Goudeau A; Coursaget P; Perrin J; Barin F; Denis F; Diop Mar I
    Prog Med Virol; 1981; 27():185-201. PubMed ID: 7232761
    [No Abstract]   [Full Text] [Related]  

  • 32. Prevention of hepatitis B virus carriage of infants using HBV vaccine in Shanghai. Preliminary report of a randomized double-blind placebo-controlled trial.
    Xu ZY; Francis DP; Liu CB; Purcell RH; Duan SC; Chen RJ; Wen YM
    Chin Med J (Engl); 1985 Sep; 98(9):623-6. PubMed ID: 3938375
    [No Abstract]   [Full Text] [Related]  

  • 33. [Vaccination against hepatitis B, in 1983, in France].
    Barbare JC; Calmus Y
    Soins; 1983 Jun; (408):11-2. PubMed ID: 6555909
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevention of perinatally transmitted hepatitis B infection.
    Lancet; 1984 Apr; 1(8383):939-41. PubMed ID: 6143872
    [No Abstract]   [Full Text] [Related]  

  • 35. Prophylaxis of hepatitis type B: immunoglobulins and vaccines.
    Zuckerman AJ
    Clin Gastroenterol; 1980 Jan; 9(1):65-83. PubMed ID: 6994953
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunization against hepatitis B].
    Heidel G
    Z Arztl Fortbild (Jena); 1982 Nov; 76(22):958-65. PubMed ID: 7170811
    [No Abstract]   [Full Text] [Related]  

  • 37. Combined passive and active immunization for preventing perinatal transmission of hepatitis B virus carrier state.
    Tada H; Yanagida M; Mishina J; Fujii T; Baba K; Ishikawa S; Aihara S; Tsuda F; Miyakawa Y; Mayumi M
    Pediatrics; 1982 Oct; 70(4):613-9. PubMed ID: 7122162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Active specific anti-hepatitis B-immunoprophylaxis: II. Protocol of an immunological approach on a random sample of the vaccinated population].
    Corridori S; Melzi d'Eril GL; Vlacos D; Gorini P; Trespi G; Campisi D; Renzetti I
    Boll Ist Sieroter Milan; 1985; 64(6):435-42. PubMed ID: 2420340
    [No Abstract]   [Full Text] [Related]  

  • 39. The evolution, implications, and applications of the hepatitis B vaccine.
    Alter HJ
    JAMA; 1982 Apr; 247(16):2272-5. PubMed ID: 7040710
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hepatitis vaccination].
    Zachoval R; Deinhardt F
    Z Gastroenterol Verh; 1982 Apr; 17():110-6. PubMed ID: 6191454
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.